UPDATE 1-China’s Junshi Biosciences raises $394 mln after pricing IPO at bottom of range -sources

HONG KONG, Dec 17 (Reuters) – Chinese biotech startup Shanghai Junshi Biosciences Co Ltd has raised $394 million after pricing its Hong Kong initial public offering (IPO) at the bottom of a marketed r…
( read original story …)


Related Post